The U.S. regulator has signed off on Corstasis Therapeutics’ Enbumyst to relieve the edema associated with congestive heart ...

The FDA has approved Enbumyst, a nasal spray formulation of bumetanide, for the treatment of edema associated CHF, and hepatic and renal disease.

Nevada-based Corstasis Therapeutics (Corstasis) has announced FDA’s approval of its bumetanide nasal spray, Enbumyst, for the ...

Increasing plasma potassium levels can improve outcomes in patients with CVD at high risk of ventricular arrhythmias, study ...

Learn how eating carbs, protein, fat, and fiber in the right order can steady blood sugar, reduce spikes, and boost energy naturally.

Fuel recommendations prior to a run depend on when one wants to eat. If you eat several hours before, focus on a mix of ...

The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease ...

The workout takes an I Go You Go format, like the stations in your Hyrox race. ‘One of you starts working through the reps, ...

A panelist discusses how interventional glaucoma emphasizes early, proactive treatment strategies to reduce IOP and medication burden while addressing patient adherence and long-term disease control.

Part of our Water Cooling 101 Series where we show you how to drain your current loop and add to it. Support us by buying ...

A new drug has shown unprecedented promise in lowering blood pressure and preventing the progression of kidney disease for ...